levofloxacin has been researched along with Bacterial Infections in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (15.79) | 18.2507 |
2000's | 55 (48.25) | 29.6817 |
2010's | 32 (28.07) | 24.3611 |
2020's | 9 (7.89) | 2.80 |
Authors | Studies |
---|---|
Brown, SD; Critchley, IA; Janjic, N; Tillotson, GS; Traczewski, MM | 1 |
Bradford, PA; Jones, CH; Mansour, TS; Petersen, PJ; Projan, SJ; Venkatesan, AM | 1 |
Bradford, PA; Jones, CH; Keeney, D; Ruzin, A; Tuckman, M | 1 |
Azéma, J; Constant, P; Daffé, M; Guidetti, B; Kiss, R; Korolyov, A; Malet-Martino, M; Roques, C | 1 |
Anderson, BE; Burda, WN; Cormier, R; Edlinger, J; Harrington, L; Kapolka, R; Kodigepalli, KM; Roma, G; Shaw, LN; Thomas, J; Turos, E | 1 |
Lynch, AS; Ma, Z | 1 |
Zhang, B | 1 |
Betson, M; Bingham, M; Doyle, P; Hallworth, S; Harvey, R; Huxley, A; Kirk, R; Moat, J; Nelson, G; Pesnot, T; Tait, M | 1 |
Courter, JD; Dandoy, CE; Davies, SM; Gardner, JC; Teusink-Cross, A | 1 |
Cheng, G; Diao, S; Jia, Z; Lu, X; Luo, J; Xin, L; Yang, M; Zeng, L; Zhang, L | 1 |
Gudima, IA; Ibishev, KS; Ismailov, RS; Kogan, MI; Naboka, YL | 1 |
Chihara, Y; Egawa, S; Fujimoto, K; Fujimoto, Y; Goto, H; Hamasuna, R; Hanaki, H; Hayami, H; Hiroshi, M; Hiyama, Y; Homma, Y; Inatomi, H; Ishihara, S; Ishikawa, K; Ito, N; Ito, T; Kamei, J; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Koda, S; Komeda, H; Masue, T; Masumori, N; Matsubara, A; Matsukawa, M; Matsumoto, K; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Miyazaki, J; Mori, K; Nishimura, K; Nishiyama, H; Oka, Y; Okumura, K; Sato, J; Shigeta, M; Shoji, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Tateda, K; Togo, Y; Torimoto, K; Tsugawa, M; Uehara, S; Wada, K; Watanabe, S; Yamada, D; Yamada, H; Yamamoto, S; Yamashita, M; Yasuda, M; Yasufuku, T | 1 |
Friehling, E; Kalpatthi, R; McCormick, M; Siripong, N; Smith, K | 1 |
Cui, HR; Hu, YS; Tang, HB; Wang, JG | 1 |
Arcaniolo, D; Calace, FP; Creta, M; Crocetto, F; De Sio, M; Fusco, F; Giordano, D; Manfredi, C; Quattrone, C | 1 |
Fu, Y; Gong, D; Lin, J; Yan, D; Yao, Q; Yu, F; Zhang, S | 1 |
Huntington, JA; Long, J; Popejoy, MW | 1 |
Flynn, PM; Gaur, AH; Hakim, H; Hayden, RT; Inaba, H; Jeha, S; Pui, CH; Stewart, T; Sun, Y; Tang, L; Wolf, J | 1 |
Copeland, V; McLaughlin, M; Trifilio, S | 1 |
Cai, HC; Cai, WW; Fan, M; Mo, DS; Shang, XJ; Wang, WP; Zhang, GW | 1 |
Bae, IG; Cho, OH; Choi, SH; Chong, YP; Kang, KC; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, MS; Lee, SO; Lee, YM; Moon, C; Park, KH; Park, SY; Ryu, BH; Woo, JH | 1 |
Bratchikov, OI; Dubonos, PA; Tyuzikov, IA | 1 |
Audisio, E; Busca, A; De Rosa, FG; Di Perri, G; Frairia, C; Marmont, F; Motta, I | 1 |
Wang, JM; Zahedi, S | 1 |
El-Shafei, A; Goldman, HB; Jones, JS; Kartha, G; Klein, EA; Unnikrishnan, R | 1 |
Loeb, S | 1 |
Kurokawa, M; Nakamura, F; Nannya, Y; Shinohara, A; Taoka, K; Uni, M; Yamazaki, S; Yoshimi, A | 1 |
Bolduc, DL; Elliott, TB; Fatanmi, OO; Kiang, JG; Ledney, GD; Newman, VL; Romaine, PL; Singh, VK; Wise, SY | 1 |
Hayashi, Y; Hino, M; Hirose, A; Kakeya, H; Koh, H; Koh, S; Nakamae, H; Nakamae, M; Nakane, T; Nakashima, Y; Nishimoto, M; Yamada, K | 1 |
Castiglione, R; Mazzarino, MC; Salemi, M; Vicari, BO; Vicari, E; Vicari, LO | 1 |
Gibas, A; Jacyna, J; Kaliszan, R; Markuszewski, MJ; Matuszewski, M; Sieczkowski, M; Siluk, D; Szerkus, O; Wiczling, P | 1 |
Chen, S; Chen, Z; Gao, XF; Kong, CZ; Na, YQ; Niu, YJ; Qiao, LD; Shi, BK; Tang, W; Wang, JY; Wang, XF; Yang, WM; Zhang, XD; Zhang, Y | 1 |
Arcos, D; Aznar, E; Gómez-Cerezo, N; Martínez-Máñez, R; Polo, L; Sancenón, F; Vallet-Regí, M; Vivancos, JL | 1 |
Botto, H; Naber, KG; Roscher, K; Schaefer, V | 1 |
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T | 1 |
Iakovlev, VP | 1 |
Carmona, IT; Diz Dios, P; Limeres Posse, J; Núñez Otero, V | 1 |
Arakawa, S; Fujisawa, M; Shigemura, K; Yamashita, M; Yasufuku, T | 1 |
Arakawa, S; Deguchi, T; Matsumoto, T; Monden, K; Nakane, K; Shimizu, T; Yasuda, M | 1 |
Petrosillo, N | 1 |
Mirone, V | 1 |
Barreto, JN; Estes, LL; Therriault, BL; Wilson, JW | 1 |
Cox, JC; Drachman, DA; Hibbard, ML; Kopelman, TR; Maly, TJ; Matthews, MR; O'Neill, PJ; Quan, AN; Vail, SJ | 1 |
Cohen, R; Grimprel, E | 1 |
Khan, MA; Rahman, MM | 1 |
Naber, KG; Roscher, K; Wagenlehner, F | 1 |
Chen, P; Cui, H; Huang, WX; Jia, ZP; Li, DT; Mao, GG; Wen, AD; Xiao, YH; Xiu, QY; Xue, F; Yang, GP | 1 |
Deuss, B; Dickgreber, N; Nagel, S; Pabst, S; Roscher, K; Salm, T; Schuette, W; Schumann, C; von Weikersthal, LF | 1 |
Ergun, H; Köseoglu-Eser, O; Mamuk, S; Melli, M; Saribas, Z | 1 |
Butler, NJ; Suhler, EB | 1 |
Figgitt, DP; Hurst, M; Lamb, HM; Scott, LJ | 1 |
Weiss, LR | 1 |
Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yoshimori, K | 1 |
Amsden, GW; Baird, IM; Simon, S; Treadway, G | 1 |
Chai, SE; Choi, HY; Hyun, JH; Jeon, SS; Woo, SH | 1 |
Bundrick, W; Heron, SP; Kahn, JB; Ray, P; Schiff, WM; Tennenberg, AM; Wiesinger, BA; Wright, PA; Wu, SC; Zadeikis, N | 1 |
Arnau, JM; Campany, D; Castells, X; Rigau, D; Vallano, A | 1 |
Croom, KF; Goa, KL | 1 |
Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T | 1 |
Alvarez-Lerma, F; Bermejo, B; León, C; Olaechea, P; Palomar, M; Sánchez, M | 1 |
Felmingham, D | 1 |
Baertsch, U; Born, B; Geiss, HK; Hamann, A; Hoppe-Tichy, T; Kusterer, K; Oberdorfer, K; Swoboda, S; von Baum, H | 1 |
Eller, J; Ioanas, M; Linnhoff, A; Lode, H | 1 |
Romanovskiĭ, AG; Sinopal'nikov, AI | 1 |
Dib, C; Durand, C; Moniot-Ville, N; Weber, P | 1 |
Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H | 1 |
Anon, JB | 1 |
Kahn, JB; Schaeffer, AJ; Tennenberg, AM; Wu, SC | 1 |
Gehanno, P; Pessey, JJ; Serrano, E | 1 |
Breen, JD; Emparanza, P; Lesinskas, E; Murray, JJ; Tawadrous, M | 1 |
Allione, B; Amadori, S; Bucaneve, G; Buelli, M; Cantaffa, R; Cilloni, D; D'Antonio, D; Del Favero, A; Deliliers, GL; Dionisi, MS; Fabbiano, F; Foà, R; Lauria, F; Martinelli, G; Martino, P; Menichetti, F; Micozzi, A; Nosari, AM; Specchia, G; Zuffa, E | 1 |
Billingham, L; Bower, M; Cullen, M; Fernando, I; Gaunt, C; Gollins, S; Hastings, M; Huddart, R; Rea, D; Simmonds, P; Stanley, A; Steven, N; Stuart, N | 1 |
Shi, YG; Ye, XY; Yu, JC; Zhang, J; Zhang, YY; Zhou, L; Zhu, DM | 1 |
Ivanov, DV; Sidorenko, SV | 1 |
Adebayo, SA; Olapade-Olaopa, EO | 1 |
Sidirenko, SV | 1 |
Almela, M; Bori, G; Gallart, X; García, S; Macule, F; Martínez, JA; Mensa, J; Sierra, J; Soriano, A; Suso, S | 1 |
Ambrusz, ME; Fisher, AC; Grossman, RF; Kahn, JB; Khashab, MM | 1 |
Arguedas, A; Blumer, J; Dagan, R; Leibovitz, E; McNeeley, DF; Melkote, R; Noel, GJ; Pichichero, M | 1 |
Kawai, H; Komiya, M; Matsumoto, T; Nakayasu, T; Shimada, J; Yamaguchi, H; Yokoyama, H | 1 |
Budanov, SV; Ivanov, DV | 1 |
Benko, R; Doro, P; Gardi, J; Hajdu, E; Matuz, M; Molnar, A; Nagy, E; Peto, Z; Soos, G | 1 |
Arguedas, A; Bagchi, P; Balis, DA; Blumer, JL; Bradley, JS; Duffy, CM; Gerbino, PG; Kauffman, RE; Noel, GJ | 1 |
Billingham, LJ; Cullen, MH; Gaunt, CH; Steven, NM | 1 |
Ambrose, PG; Anon, JB; Bhavnani, SM; Drusano, GL; Jones, RN; Kahn, J; Okusanya, OO; Paglia, MR | 1 |
Anderson, VR; Perry, CM | 1 |
Gwaltney, JM | 1 |
Ishitoya, S; Kamoto, T; Ogawa, O; Okumura, K; Segawa, T; Yamamoto, S | 1 |
Bryson, HM; Davis, R | 1 |
Geweniger, KH; Isert, D; Iyer, P; Klesel, N; Koletzki, P; Limbert, M; Markus, A; Riess, G; Schramm, H | 1 |
Bodey, GP; Dholakia, N; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
Saito, A | 1 |
Fujimoto, K; Hayashi, T; Osada, T; Sakurai, T; Yamamura, K | 1 |
Goldstein, EJ | 1 |
Ernst, EJ; Ernst, ME; Klepser, ME | 1 |
Berman, AL; Chow, AT; Corrado, M; Dornseif, B; Drusano, GL; Fowler, CL; Natarajan, J; Preston, SL; Reichl, V | 1 |
Anthony, KE; Fowler, CL; Kim, SS; Kopp, EJ; LoCoco, JM; Sydnor, TA | 1 |
Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
Redondo Sánchez, J | 1 |
Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
Fukuyama, M; Furuhata, K; Hara, T; Oonaka, K; Sunakawa, K | 1 |
Almela, M; Alvárez, JL; García, S; Mensa, J; Ortega, M; Soriano, A; Soriano, E; Tomás, X | 1 |
Scheen, AJ | 1 |
Norrby, SR | 1 |
Sato, K; Tanaka, M; Wada, K | 1 |
Zhan, S; Zhang, Z; Zhen, J | 1 |
Lizzano, R; Mangiarotti, B; Trinchieri, A | 1 |
Barrett, JF; Foleno, B; Fu, KP; Isaacson, DM; Lafredo, SC; Rosenthale, ME; Tobia, AJ | 1 |
Doi, S; Fujimoto, M; Kinoshita, H; Morimoto, K; Nakatani, S; Ohmori, K; Ohno, K; Sakai, K; Ueda, T; Yamazaki, O | 1 |
Araki, H; Cho, N; Fukunaga, K; Ichikawa, K; Kimura, T; Kunii, K; Shimizu, A | 1 |
Hirayama, H; Matsuda, S; Oh, K | 1 |
24 review(s) available for levofloxacin and Bacterial Infections
Article | Year |
---|---|
Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Comparative effectiveness and safety of antibiotic prophylaxis during induction chemotherapy in children with acute leukaemia: a systematic review and meta-analysis.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Ciprofloxacin; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Levofloxacin | 2023 |
Assessment of the risk of musculoskeletal adverse events associated with fluoroquinolone use in children: A meta-analysis.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Case-Control Studies; Child; Child, Preschool; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Musculoskeletal System; Naphthyridines; Retrospective Studies; Sensitivity and Specificity; Topoisomerase II Inhibitors | 2020 |
[Present positioning of levofloxacin in chemotherapy of bacterial infections].
Topics: Anti-Bacterial Agents; Bacterial Infections; Humans; Levofloxacin; Ofloxacin | 2008 |
Efficacy of fluoroquinolones against pathogenic oral bacteria.
Topics: Aza Compounds; Bacteria; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Mouth Diseases; Moxifloxacin; Ofloxacin; Oral Medicine; Quinolines | 2009 |
[From cystitis to bacterial prostatitis: experience with levofloxacin].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cystitis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Multicenter Studies as Topic; Ofloxacin; Practice Guidelines as Topic; Prostatitis; Pyelonephritis; Randomized Controlled Trials as Topic; Risk Factors; Urethritis; Urinary Tract Infections | 2009 |
Levofloxacin revisited.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Gastrointestinal Diseases; Humans; Levofloxacin; Ofloxacin; Stevens-Johnson Syndrome | 2011 |
Levofloxacin: an updated review of its use in the treatment of bacterial infections.
Topics: Bacterial Infections; Clinical Trials as Topic; Gram-Negative Bacteria; Humans; Levofloxacin; Ofloxacin | 2002 |
Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Topics: Anti-Infective Agents; Area Under Curve; Bacterial Infections; Biological Availability; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Humans; Intestinal Absorption; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Randomized Controlled Trials as Topic; Tissue Distribution | 2003 |
Comparative antimicrobial susceptibility of respiratory tract pathogens.
Topics: Asia, Eastern; Bacterial Infections; Drug Resistance, Microbial; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Respiratory Tract Diseases; Streptococcus pneumoniae; Sulfamethoxazole; Trimethoprim | 2004 |
[Levofloxacin: role and place in the treatment of infections of the lower respiratory tracts].
Topics: Anti-Bacterial Agents; Bacterial Infections; Central Nervous System; Drug Resistance, Bacterial; Humans; Levofloxacin; Musculoskeletal System; Ofloxacin; Respiratory System; Respiratory Tract Infections | 2004 |
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Levofloxacin; Meta-Analysis as Topic; Moxifloxacin; Ofloxacin; Practice Guidelines as Topic; Quinolines; Rhinitis; Sinusitis; Streptococcus pneumoniae | 2005 |
[Levofloxacin nowadays].
Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Bacterial; Humans; Levofloxacin; Ofloxacin | 2006 |
[Levofloxacin and other antibacterial drugs].
Topics: Anti-Bacterial Agents; Bacterial Infections; Dermatitis; Dosage Forms; Humans; Levofloxacin; Ofloxacin; Otitis Media; Respiratory Tract Infections; Sinusitis; Urinary Tract Infections | 2006 |
Levofloxacin : a review of its use as a high-dose, short-course treatment for bacterial infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Community-Acquired Infections; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Ofloxacin; Pneumonia | 2008 |
Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.
Topics: Administration, Oral; Aging; Bacteria; Bacterial Infections; Biological Availability; Drug Interactions; Female Urogenital Diseases; Half-Life; Humans; Levofloxacin; Male Urogenital Diseases; Microbial Sensitivity Tests; Ofloxacin; Respiratory Tract Infections; Stereoisomerism | 1994 |
[[New antimicrobial agent series XLVII]: levofloxacin].
Topics: Absorption; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacteria; Bacterial Infections; Drug Interactions; Female; Humans; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Ofloxacin; Tissue Distribution | 1994 |
Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
Topics: Anti-Infective Agents; Bacteria, Anaerobic; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Safety; Syndrome | 1996 |
Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Naphthyridines; Ofloxacin | 1997 |
New fluoroquinolone antibiotics.
Topics: Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Piperazines; Respiratory Tract Infections | 1999 |
[Levofloxacin for prevalent infections in primary care medicine].
Topics: Anti-Infective Agents; Bacterial Infections; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Primary Health Care; Respiratory Tract Infections; Urinary Tract Infections | 1999 |
Levofloxacin.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Clinical Trials as Topic; Humans; Levofloxacin; Ofloxacin | 1999 |
[Injectable quinolones].
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; Injections, Intravenous; Levofloxacin; Ofloxacin | 2001 |
[Use of levofloxacin in the antibiotic prophylaxis for diagnostic procedures in urology].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Bacteriuria; Biopsy; Comorbidity; Diagnostic Techniques, Urological; Disease Susceptibility; Drug Evaluation; Endoscopy; Equipment Contamination; Humans; Incidence; Levofloxacin; Lithotripsy; Male; Middle Aged; Ofloxacin; Premedication; Prospective Studies; Prostate; Risk Factors; Urinary Catheterization; Urinary Tract Infections | 2002 |
30 trial(s) available for levofloxacin and Bacterial Infections
Article | Year |
---|---|
[Extended culture study as a keypoint to rethinking antibiotic therapy for chronic bacterial prostatitis].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Humans; Levofloxacin; Male; Prostatitis | 2023 |
Escherichia coli Nissle 1917 as adjuvant therapy in patients with chronic bacterial prostatitis: a non-blinded, randomized, controlled trial.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Combined Modality Therapy; Escherichia coli; Humans; Levofloxacin; Male; Middle Aged; Prostatitis; Treatment Outcome; Young Adult | 2021 |
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections | 2017 |
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Cohort Studies; Drug Resistance, Microbial; Female; Humans; Induction Chemotherapy; Levofloxacin; Logistic Models; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
A multi-center, controlled, randomized, open-label clinical study of levofloxacin for preventing infection during the perioperative period of ultrasound-guided transrectal prostate biopsy.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; China; Humans; Image-Guided Biopsy; Incidence; Levofloxacin; Male; Middle Aged; Preoperative Care; Prospective Studies; Prostatic Neoplasms; Treatment Outcome | 2016 |
Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2008 |
[The clinical efficacy and safety of intravenous levofloxacin in the treatment of 4888 patients with bacterial infections: a multi-center trial].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Young Adult | 2009 |
Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Female; Humans; Leukemia; Levofloxacin; Male; Neutropenia; Ofloxacin; Single-Blind Method | 2009 |
[A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Double-Blind Method; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Young Adult | 2011 |
Randomized phase III trial of docetaxel plus carboplatin with or without levofloxacin prophylaxis in elderly patients with advanced non-small cell lung cancer: the APRONTA trial.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carboplatin; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Docetaxel; Double-Blind Method; Dyspnea; Female; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Leukopenia; Levofloxacin; Lung Neoplasms; Male; Middle Aged; Neutropenia; Ofloxacin; Pain; Taxoids | 2011 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchitis, Chronic; Cefuroxime; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2002 |
Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Double-Blind Method; Female; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Multivariate Analysis; Ofloxacin | 2003 |
Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Drug Administration Schedule; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostatitis; Treatment Outcome | 2003 |
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome | 2004 |
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Clarithromycin; Disease Progression; Double-Blind Method; Female; Germany; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Statistics, Nonparametric; Treatment Outcome | 2004 |
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Topics: Amyloidosis; Anemia, Aplastic; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Humans; Leukemia; Levofloxacin; Lymphoma; Middle Aged; Multiple Myeloma; Neutropenia; Ofloxacin | 2005 |
Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Double-Blind Method; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2005 |
[Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
Topics: Acute Disease; Adolescent; Adult; Africa, Southern; Aged; Bacterial Infections; Female; France; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Middle Aged; Moraxella catarrhalis; Moraxellaceae Infections; Ofloxacin; Pneumococcal Infections; Prospective Studies; Risk; Sinusitis; Staphylococcal Infections; Treatment Outcome; Tunisia | 2005 |
Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Chemistry, Pharmaceutical; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; International Cooperation; Levofloxacin; Male; Maxillary Sinusitis; Microspheres; Middle Aged; Ofloxacin; Probability; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Bacterial Infections; Double-Blind Method; Female; Fever of Unknown Origin; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Risk | 2005 |
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Double-Blind Method; Female; Fever; Hospitalization; Humans; Leukocyte Count; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Risk; Systemic Inflammatory Response Syndrome | 2005 |
Levofloxacin 750 mg QD for five days versus amoxicillin/clavulanate 875 mg/125 mg BID for ten days for treatment of acute bacterial exacerbation of chronic bronchitis: a post hoc analysis of data from severely ill patients.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Drug Administration Schedule; Female; Humans; Levofloxacin; Male; Ofloxacin | 2006 |
An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Child, Preschool; Exudates and Transudates; Female; Humans; Infant; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Otitis Media; Paracentesis; Treatment Outcome | 2006 |
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Levofloxacin; Male; Musculoskeletal Diseases; Ofloxacin; Prospective Studies | 2007 |
Rational selection of patients for antibacterial prophylaxis after chemotherapy.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacterial Infections; Double-Blind Method; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Neoplasms; Ofloxacin; Patient Selection; Placebos; Risk Factors | 2007 |
Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Female; Humans; Levofloxacin; Male; Maxillary Sinus; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Ofloxacin; Peroxidase; Pilot Projects; Plasma; Radiography; Time Factors; United States | 2008 |
Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Cystitis; Fluoroquinolones; Humans; Levofloxacin; Male; Naphthyridines; Ofloxacin; Prospective Studies; Prostate; Prostatitis; Rectum | 2008 |
Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials.
Topics: Adult; Anti-Infective Agents; Area Under Curve; Bacterial Infections; Bayes Theorem; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Levofloxacin; Logistic Models; Male; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1998 |
Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Exudates and Transudates; Female; Haemophilus influenzae; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Ofloxacin; Prospective Studies; Sinusitis; Staphylococcus aureus; Streptococcus pneumoniae | 1998 |
[Tolerability and safety of levofloxacinin long-term treatment].
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Female; Humans; Levofloxacin; Long-Term Care; Male; Middle Aged; Ofloxacin; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections | 2000 |
60 other study(ies) available for levofloxacin and Bacterial Infections
Article | Year |
---|---|
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Geography; Haemophilus influenzae; Health Surveys; Humans; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2007 |
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Enzyme Inhibitors; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin | 2009 |
Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Clinical Trials, Phase III as Topic; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Humans; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Proteus mirabilis; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline | 2009 |
Synthesis of lipophilic dimeric C-7/C-7-linked ciprofloxacin and C-6/C-6-linked levofloxacin derivatives. Versatile in vitro biological evaluations of monomeric and dimeric fluoroquinolone derivatives as potential antitumor, antibacterial or antimycobacte
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Line, Tumor; Ciprofloxacin; Dimerization; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Ofloxacin | 2011 |
Studies on the antimicrobial properties of N-acylated ciprofloxacins.
Topics: Acylation; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bartonella; Bartonella Infections; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2012 |
Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Rifamycins; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Novel C-7 carbon substituted fourth generation fluoroquinolones targeting N. Gonorrhoeae infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Carbon; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Structure; Neisseria gonorrhoeae; Structure-Activity Relationship | 2020 |
Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Levofloxacin; Retrospective Studies; Young Adult | 2022 |
The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Humans; Japan; Klebsiella pneumoniae; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Proteus mirabilis; Pseudomonas aeruginosa; Urinary Tract Infections; Vancomycin; Young Adult | 2020 |
Cost-effectiveness of levofloxacin prophylaxis against bacterial infection in pediatric patients with acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Intensive Care Units; Leukemia, Myeloid, Acute; Levofloxacin; Male; Prognosis; Retrospective Studies | 2020 |
Insight into levofloxacin loaded biocompatible electrospun scaffolds for their potential as conjunctival substitutes.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biocompatible Materials; Cellulose; Conjunctiva; Conjunctival Diseases; Drug Delivery Systems; Fibroins; Levofloxacin; Membranes, Artificial; Nanofibers; Polyesters; Rabbits; Tissue Scaffolds; Wound Healing | 2021 |
Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem-cell transplantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Prognosis; Retrospective Studies | 2018 |
[Fosfomycin tromethamine inhibits the expressions of TNF-α, IL-8 and IL-6 in the prostate tissue of rats with chronic bacterial prostatitis].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Fosfomycin; Interleukin-6; Interleukin-8; Levofloxacin; Male; Prostate; Prostatitis; Random Allocation; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2018 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Empirical Research; Enterobacteriaceae; Female; Gene Expression; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Spine; Streptococcus; Vancomycin | 2019 |
[Justification of a use of additional antioxidant therapy in experimental models of chronic bacterial prostatitis].
Topics: Adult; Animals; Anti-Bacterial Agents; Antioxidants; Bacterial Infections; Disease Models, Animal; Humans; Levofloxacin; Lipid Peroxidation; Male; Oxidative Stress; Prostatitis; Rats; Superoxide Dismutase | 2019 |
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Bacteria; Bacterial Infections; Ciprofloxacin; Female; Fluoroquinolones; Humans; Incidence; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2013 |
A possible case of levofloxacin-associated amnesia, depression, and paresthesia.
Topics: Amnesia; Anti-Bacterial Agents; Bacterial Infections; Depression; Female; Humans; Levofloxacin; Middle Aged; Paresthesia | 2014 |
For Single Dosing, Levofloxacin Is Superior to Ciprofloxacin When Combined With an Aminoglycoside in Preventing Severe Infections After Prostate Biopsy.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fluoroquinolones; Humans; Image-Guided Biopsy; Levofloxacin; Male; Middle Aged; Postoperative Complications; Prostate; Retrospective Studies; Severity of Illness Index; Ultrasonography, Interventional | 2015 |
Editorial Comment.
Topics: Aminoglycosides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Male; Postoperative Complications; Prostate | 2015 |
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Primary Prevention; Retrospective Studies; Sample Size | 2015 |
Combined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured mice.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Bacterial Infections; Chemokines; Cord Factors; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; Gamma Rays; Growth Substances; Immunologic Factors; Levofloxacin; Lipid A; Mice; Radiation Injuries, Experimental; Sepsis; Skin; Wound Infection | 2015 |
Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Opportunistic Infections; Polymyxin B; Retrospective Studies; Transplantation, Homologous; Young Adult | 2015 |
Effect of levofloxacin treatment on semen hyperviscosity in chronic bacterial prostatitis patients.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Chlamydia; Chronic Disease; Humans; Infertility, Male; Interleukin-6; Italy; Leukocyte Count; Levofloxacin; Male; Prostatitis; Reactive Oxygen Species; Semen; Sperm Motility; Treatment Outcome; Tumor Necrosis Factor-alpha; Viscosity; Young Adult | 2016 |
Ultra-high performance liquid chromatographic determination of levofloxacin in human plasma and prostate tissue with use of experimental design optimization procedures.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Chromatography, High Pressure Liquid; Endosonography; Humans; Image-Guided Biopsy; Levofloxacin; Limit of Detection; Male; Middle Aged; Prostate | 2016 |
Molecular gates in mesoporous bioactive glasses for the treatment of bone tumors and infection.
Topics: Bacterial Infections; Bone Neoplasms; Cell Line, Tumor; Ceramics; Doxorubicin; Drug Delivery Systems; Humans; Levofloxacin; Porosity | 2017 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2010 |
Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Male; Ofloxacin; Prostate; Prostatitis; Rectum; Retrospective Studies; Risk Factors; Ultrasound, High-Intensity Focused, Transrectal | 2009 |
Microbiological outcome of complicated urinary tract infections treated with levofloxacin: a pharmacokinetic/pharmacodynamic analysis.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Computer Simulation; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Serum; Treatment Outcome; Urinary Tract Infections; Urine | 2010 |
[Experience accumulated in hospital setting with levofloxacin, in monotherapy and in association therapy].
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hospital Departments; Humans; Levofloxacin; Multicenter Studies as Topic; Neoplasms; Neutropenia; Ofloxacin; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2009 |
Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.
Topics: Antibiotic Prophylaxis; Bacterial Infections; Cohort Studies; Doxycycline; Drug Resistance, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Ofloxacin; Penicillins; Retrospective Studies; Transplantation, Homologous | 2010 |
Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tobramycin | 2010 |
[Levofloxacin in children].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Child; Community-Acquired Infections; Humans; Levofloxacin; Mycoplasma pneumoniae; Ofloxacin; Otitis Media; Pneumococcal Infections; Pneumonia; Sinusitis; Staphylococcus aureus; Streptococcus pneumoniae | 2010 |
[Practice management of chronic bacterial prostatitis with levofloxacin].
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacterial Infections; Chronic Disease; Escherichia coli Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Prostatitis; Recurrence; Staphylococcal Infections | 2011 |
Critical appraisal of air pouch infection model in rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Exudates and Transudates; Female; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin | 2012 |
Levofloxacin-associated panuveitis with chorioretinal lesions.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Bites and Stings; Female; Fluorescein Angiography; Glucocorticoids; Humans; Levofloxacin; Ofloxacin; Panuveitis; Prednisone; Retinal Diseases; Tomography, Optical Coherence; Visual Acuity | 2012 |
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Ciprofloxacin; Dosage Forms; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Macrolides; Ofloxacin; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Urinary Tract Infections | 2002 |
Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy.
Topics: Adenocarcinoma; Administration, Oral; Administration, Rectal; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacterial Infections; Biomarkers, Tumor; Biopsy, Needle; Bisacodyl; Cefixime; Epididymitis; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Retrospective Studies; Risk Factors; Ultrasonography, Interventional | 2003 |
[Use of levofloxacin in the hospital].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Utilization; Female; Guideline Adherence; Hospitals, University; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Spain | 2003 |
[Observational study investigating the use of levofloxacin in ICU patients].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Arrhythmias, Cardiac; Bacterial Infections; Chemical and Drug Induced Liver Injury; Community-Acquired Infections; Comorbidity; Critical Care; Cross Infection; Diarrhea; Drug Resistance; Drug Therapy, Combination; Drug Utilization; Female; Humans; Infusions, Parenteral; Intensive Care Units; Levofloxacin; Male; Middle Aged; Ofloxacin; Prospective Studies; Respiration, Artificial; Respiratory Tract Infections; Spain | 2004 |
Tissue and serum levofloxacin concentrations in diabetic foot infection patients.
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Chromatography, High Pressure Liquid; Diabetic Foot; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Tissue Distribution | 2004 |
[Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community].
Topics: Anti-Infective Agents, Urinary; Bacterial Infections; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Staphylococcus aureus; Urinary Tract Infections | 2005 |
[Study of pharmacokinetics/pharmacodynamics of levofloxacin].
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests | 2005 |
[Results of the study on antibiotic resistance emergence among pathogens of community-acquired urinary tract infections in Moscow. Phase I].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacterial Infections; Cephalosporins; Community-Acquired Infections; Drug Resistance; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Male; Middle Aged; Moscow; Ofloxacin; Urinary Tract Infections | 2005 |
Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Ciprofloxacin; Humans; Levofloxacin; Male; Ofloxacin; Prostate-Specific Antigen; Prostatitis | 2006 |
Treatment of acute post-surgical infection of joint arthroplasty.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bacterial Infections; Debridement; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Male; Ofloxacin; Prosthesis-Related Infections; Rifampin; Treatment Outcome | 2006 |
Post-marketing surveillance of the safety of levofloxacin in Japan.
Topics: Achilles Tendon; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chemical and Drug Induced Liver Injury; Female; Humans; Hypoglycemia; Japan; Levofloxacin; Liver Diseases; Long QT Syndrome; Male; Middle Aged; Ofloxacin; Photosensitivity Disorders; Product Surveillance, Postmarketing; Seizures; Torsades de Pointes | 2007 |
Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Ventilator-Associated; Prospective Studies | 2007 |
Commentary on "Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis" by Ambrose et al.
Topics: Anti-Bacterial Agents; Bacterial Infections; Humans; Levofloxacin; Maxillary Sinusitis; Ofloxacin | 2008 |
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.
Topics: Abscess; Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Female; Granuloma; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Pyelonephritis; Rats; Rats, Wistar; Sepsis; Stereoisomerism; Streptococcus pneumoniae | 1995 |
Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones.
Topics: Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Microbial Sensitivity Tests; Neoplasms; Ofloxacin; Stereoisomerism | 1994 |
Effect of levofloxacin-albumin Dacron graft on graft infection.
Topics: Animals; Bacterial Infections; Levofloxacin; Male; Ofloxacin; Polyethylene Terephthalates; Rats; Rats, Sprague-Dawley; Tissue Transplantation | 1995 |
Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Bites and Stings; Bites, Human; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Species Specificity; Wound Infection | 1998 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
[Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Blood; Campylobacter; Electrolytes; Enteritis; Escherichia coli; Escherichia coli O157; Fosfomycin; Humans; Hydrogen-Ion Concentration; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Salmonella; Shigella | 2000 |
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Bronchitis; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia, Bacterial; Sinusitis; Urinary Tract Infections | 2000 |
[Adverse drug reaction and rational use of levofloxacin: a prospective study].
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Anti-Infective Agents; Bacterial Infections; Drug Combinations; Female; Humans; Levofloxacin; Male; Middle Aged; Multicenter Studies as Topic; Ofloxacin | 2001 |
In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Ofloxacin; Stereoisomerism | 1992 |
Efficacy of a new quinolone, levofloxacin in patients with surgical infections.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Postoperative Complications; Surgical Wound Infection | 1992 |
[Pharmacokinetic and clinical evaluation of levofloxacin in obstetrics and gynecology].
Topics: Administration, Oral; Adult; Bacterial Infections; Female; Genital Diseases, Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Ovary; Uterus | 1992 |
[Pharmacokinetic and clinical evaluation of levofloxacin in obstetrical and gynecological field].
Topics: Administration, Oral; Adult; Bacterial Infections; Female; Genital Diseases, Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Ovary; Uterus | 1992 |